Search

Search Constraints

You searched for: Author/Creator Lebray, Pascal

Search Results

1. Sofosbuvir‐based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation. Issue 10 (October 2016)

2. 12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation. Issue 4 (5th October 2018)

3. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation. Issue 5 (19th July 2021)

4. Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease. Issue 10 (17th October 2018)

5. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11, 226 Patients. Issue 10 (25th October 2018)

6. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. (3rd December 2019)

7. LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis. Issue 3 (19th December 2018)

8. Rate of employment after liver transplantation in France: a single-centre study. Issue 2 (February 2016)

9. Diagnosis and management of hepatic encephalopathy: The French recommendations. (24th January 2023)

10. Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme. (8th March 2017)